Absci Company
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Investors
Last Funding Type:
Venture - Series Unknown
Funding Status:
IPO
Headquarters:
Vancouver, Washington, United States
Founded Date:
2011-01-01
Last Funding Date:
2021-03-23
Total Funding:
237859989.0
Technology:
['BioTech & HealthTech']
Employee Number:
101-250
Estimated Revenue:
$10M to $50M
Investors Number:
23.0
Industry:
Medical BioTech